SCHEMBL7963090

SCHEMBL7963090

CN(C(=O)c1ccc(Cl)c(Cl)c1)C1c2ccccc2CC1N1CCCC1

nearest known ligand 0.81

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 3/20 0.61
▸ CYP1A2 P05177 1/20 0.61
▸ CYP3A4 P08684 1/20 0.61
▸ CYP2D6 P10635 1/20 0.61
▸ TSHR P16473 1/20 0.61
▸ CYP2C19 P33261 1/20 0.61
▸ OPRM1 P35372 3/20 0.57
▸ OPRK1 P41145 3/20 0.57
▸ OPRD1 P41143 2/20 0.57
▸ SLC9A3 P48764 1/20 0.46
▸ HSD11B1 P28845 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9772450 1.00 SIGMAR1 (0.61) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL9492502 0.90 SIGMAR1 (0.66) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL9704626 0.90 SIGMAR1 (0.71) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL7962240 0.87 SIGMAR1 (0.47) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL9772385 0.87 SIGMAR1 (0.47) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL9813884 0.85 SIGMAR1 (0.70) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL9749142 0.85 SIGMAR1 (0.70) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL9813889 0.85 SIGMAR1 (0.70) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
1,2-Dichlorobenzene SCHEMBL9643933 0.83 SIGMAR1 (0.54) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL7962880 0.82 OPRK1 (0.82) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6271395-B1 E.G.,(.+-.)-N-(2,3-DIHYDRO-2-(1-PYRROLIDINYL)-1H-INDEN-1-Y1) -2 ,4-DINITRO-N-METHYL-BENZENE-ACETAMIDE; STRONG AFFINITY FOR OPTICAL RECEPTORS, CENTRAL ANALGESIC, DIURETIC, ANTIARRYTHMIC, HYPOTENSIVE AND ANTIISCHEMIC ACTIVITY. HOECHST MARION ROUSSOL (FR) 2001-08-07 — — US disclosed
EP-0258096-B1 INDANE DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AS MEDICINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THE INTERMEDIATES OBTAINED ROUSSEL-UCLAF (FR) 1992-09-09 — — EP disclosed
EP-0258096-A2 Indane derivatives, process for their preparation, their use as medicines, pharmaceutical compositions containing them and the intermediates obtained ROUSSEL-UCLAF (FR) 1988-03-02 — — EP disclosed
Send feedback